Literature DB >> 20049645

Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease.

Pere-Joan Cardona1.   

Abstract

Once Mycobacterium tuberculosis infects a person it can persist for a long time in a process called latent tuberculosis infection (LTBI). LTBI has traditionally been considered to involve the bacilli remaining in a non-replicating state (dormant) in old lesions but still retaining their ability to induce reactivation and cause active tuberculosis (TB) once a disruption of the immune response takes place. The present review aims to challenge these concepts by including recent experimental data supporting LTBI as a constant endogenous reinfection process as well as the recently introduced concepts of damage-response and tolerance frameworks to explain TB induction. These frameworks highlight the key role of an exaggerated and intolerant host response against M. tuberculosis bacilli which induces the classical TB cavity in immunocompetent adults once the constant endogenous reinfection process has resulted in the presence of bacilli in the upper lobes, where they can grow faster and the immune response is delayed. This essay intends to provide new clues to understanding the induction of TB in non-immunosuppressed patients.

Entities:  

Mesh:

Year:  2010        PMID: 20049645     DOI: 10.1007/s00005-009-0062-5

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  27 in total

1.  Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.

Authors:  María Dolores Juárez-Rodríguez; Lourdes T Arteaga-Cortés; Rebin Kader; Roy Curtiss; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

3.  Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.

Authors:  Zahoor Ahmad; Mostafa M Fraig; Michael L Pinn; Sandeep Tyagi; Eric L Nuermberger; Jacques H Grosset; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2011-05-20       Impact factor: 5.790

4.  Outbreak of transient conversions of the QuantiFERON-TB Gold In-Tube test in laboratory health care worker screenings.

Authors:  Caterina Zanetti; Marta Peracchi; Diego Zorzi; Silvia Fiorio; Loredana Fallico; Giorgio Palù
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

Review 5.  Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response.

Authors:  Jacqueline M Achkar; Elizabeth R Jenny-Avital
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

6.  Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosis.

Authors:  Marian Loveday; Babu Sunkari; Ben J Marais; Iqbal Master; James C M Brust
Journal:  Arch Dis Child       Date:  2016-04-04       Impact factor: 3.791

7.  Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons.

Authors:  Maria Florencia Quiroga; Matias Tomas Angerami; Natalia Santucci; Diego Ameri; Jose Luis Francos; Jorge Wallach; Omar Sued; Pedro Cahn; Horacio Salomón; Oscar Bottasso
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

Review 8.  A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Clin Dev Immunol       Date:  2011-03-13

9.  Within the Enemy's Camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis.

Authors:  Christopher R Shaler; Carly N Horvath; Mangalakumari Jeyanathan; Zhou Xing
Journal:  Front Immunol       Date:  2013-02-14       Impact factor: 7.561

10.  Pulmonary tuberculosis incidence and risk factors in rural areas of China: a cohort study.

Authors:  Wei Chen; Wen Shu; Min Wang; Yongchun Hou; Yinyin Xia; Weiguo Xu; Liqiong Bai; Shaofa Nie; Shiming Cheng; Yihua Xu
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.